[Acanthamoeba keratitis treated with propamidine and polyhexamethyl biguanide (PHMB)]
- PMID: 12090104
[Acanthamoeba keratitis treated with propamidine and polyhexamethyl biguanide (PHMB)]
Abstract
Background: The diagnosis of acanthamoeba keratitis has increased since 1985 due to the massive use of contact lenses and a better knowledge of the disease by ophthalmologists. The use of biassociated therapy has resulted in a better prognosis and lower complication rate.
Aim: To report patients with acanthamoeba keratitis treated with the association of propamidine (Brolene) and polyhexamethylbiguanide (PHMB) 0.02%.
Patients and methods: Retrospective analysis of 27 patients (31 eyes) with acanthamoeba keratitis (bilateral in four cases), diagnosed by culture, biopsy or characteristic clinical features.
Results: Ninety six percent of patients used rigid contact lenses. Acanthamoeba cultures were positive in 71% of cases. The delay in the diagnosis was between 1 and 5 months. Early treatment was possible in 29% of patients. Infection was irradicated in all cases with the biassociated therapy. A tectonic keratoplasty to treat a trophic perforation was done in eight eyes. No patient required therapeutic keratoplasty to resolve the infection. Visual acuity at the end of follow up was better than 20/40 in nine patients and in eight it was in the range of count fingers or less.
Conclusions: In patients with the clinical picture of acanthamoeba keratitis, early or late antiamoebic treatment is warranted even in the absence of positive cultures. The visual results of the treatment are highly dependent on the precocity of treatment. Prevention is imperative and is based on a strict contact lens hygiene.
Similar articles
-
Outcome of acanthamoeba keratitis treated with polyhexamethyl biguanide and propamidine.Ophthalmology. 1997 Oct;104(10):1587-92. doi: 10.1016/s0161-6420(97)30092-x. Ophthalmology. 1997. PMID: 9331195
-
Persistently culture positive acanthamoeba keratitis: in vivo resistance and in vitro sensitivity.Ophthalmology. 2003 Aug;110(8):1593-600. doi: 10.1016/S0161-6420(03)00481-0. Ophthalmology. 2003. PMID: 12917179
-
Acanthamoeba keratitis associated with misuse of daily disposable contact lenses.Cont Lens Anterior Eye. 2006 Dec;29(5):269-71. doi: 10.1016/j.clae.2006.08.002. Epub 2006 Sep 1. Cont Lens Anterior Eye. 2006. PMID: 16945570
-
Treatment of Acanthamoeba keratitis.Expert Rev Anti Infect Ther. 2003 Aug;1(2):205-8. doi: 10.1586/14787210.1.2.205. Expert Rev Anti Infect Ther. 2003. PMID: 15482114 Review.
-
[Treatment of Acanthamoeba keratitis: possibilities, problems, and new approaches].Wien Klin Wochenschr. 2003;115 Suppl 3:10-7. Wien Klin Wochenschr. 2003. PMID: 15508774 Review. German.
Cited by
-
The resistance of the yeast Saccharomyces cerevisiae to the biocide polyhexamethylene biguanide: involvement of cell wall integrity pathway and emerging role for YAP1.BMC Mol Biol. 2011 Aug 19;12:38. doi: 10.1186/1471-2199-12-38. BMC Mol Biol. 2011. PMID: 21854579 Free PMC article.
-
Polyhexamethylene biguanide functionalized cationic silver nanoparticles for enhanced antimicrobial activity.Nanoscale Res Lett. 2012 May 24;7(1):267. doi: 10.1186/1556-276X-7-267. Nanoscale Res Lett. 2012. PMID: 22625664 Free PMC article.
-
Pathogenesis of acanthamoeba keratitis.Ocul Surf. 2010 Apr;8(2):70-9. doi: 10.1016/s1542-0124(12)70071-x. Ocul Surf. 2010. PMID: 20427010 Free PMC article. Review.
-
The effect of the disulfideisomerase domain containing protein in the defense against polyhexamethylene biguanide of highly tolerant Acanthamoeba at the trophozoite stage.Int J Parasitol Drugs Drug Resist. 2016 Dec;6(3):251-257. doi: 10.1016/j.ijpddr.2016.11.001. Epub 2016 Nov 14. Int J Parasitol Drugs Drug Resist. 2016. PMID: 27888770 Free PMC article.
-
Cationic antimicrobial polymers and their assemblies.Int J Mol Sci. 2013 May 10;14(5):9906-46. doi: 10.3390/ijms14059906. Int J Mol Sci. 2013. PMID: 23665898 Free PMC article. Review.